| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.YMETH.2014.11.001 |
| P698 | PubMed publication ID | 25461816 |
| P50 | author | Xavier Matias-Guiu Guia | Q62016438 |
| Maria Santacana | Q39032703 | ||
| Oscar Maiques | Q44529136 | ||
| P2093 | author name string | Xavier Dolcet | |
| Núria Eritja | |||
| Xavier Gonzalez-Tallada | |||
| P2860 | cites work | Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2 | Q22253866 |
| PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. | Q54584081 | ||
| Immunohistochemical markers for prognosis of anaplastic astrocytomas. | Q55473298 | ||
| PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration | Q59313170 | ||
| The Differentiated State of Normal and Malignant Cells or How to Define a “Normal” Cell in Culture | Q70763724 | ||
| Isolation and culture of human endometrial cells in a three-dimensional culture system | Q72731559 | ||
| PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma | Q73374555 | ||
| PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases | Q73622060 | ||
| PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy | Q74715361 | ||
| Cell adhesion molecules as tumour suppressors | Q75293348 | ||
| Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma | Q77879703 | ||
| Phosphatidylserine is polarized and required for proper Cdc42 localization and for development of cell polarity | Q85028296 | ||
| PTEN function: how normal cells control it and tumour cells lose it | Q24528114 | ||
| A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q24632651 | ||
| miR-19 is a key oncogenic component of mir-17-92 | Q24652326 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Advances in the formation, use and understanding of multi-cellular spheroids | Q26828808 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN | Q28141881 | ||
| Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
| PTEN1 is frequently mutated in primary endometrial carcinomas | Q28250937 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Pten is essential for embryonic development and tumour suppression | Q28509238 | ||
| Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems | Q28586004 | ||
| Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures | Q29547700 | ||
| MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN. | Q33755798 | ||
| A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis. | Q33882422 | ||
| Accommodating haploinsufficient tumor suppressor genes in Knudson's model | Q33986221 | ||
| Mutations of the human PTEN gene | Q33988995 | ||
| Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer | Q34103462 | ||
| Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation | Q34109986 | ||
| Prognostic significance of miR-205 in endometrial cancer | Q34238901 | ||
| Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible | Q34574472 | ||
| The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures | Q34674397 | ||
| Comprehensive miRNA profiling of surgically staged endometrial cancer | Q34779785 | ||
| Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. | Q35185712 | ||
| Considerations when analyzing the methylation status of PTEN tumor suppressor gene | Q35788734 | ||
| Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing | Q35926060 | ||
| MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. | Q35974749 | ||
| ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance | Q35990014 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Cell polarity in development and cancer. | Q36925556 | ||
| Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas | Q37038863 | ||
| mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss | Q37156750 | ||
| Mmu-microRNA-200a overexpression leads to implantation defect by targeting phosphatase and tensin homolog in mouse uterus | Q37280170 | ||
| The epithelial polarity program: machineries involved and their hijacking by cancer. | Q37333603 | ||
| Polarity proteins in migration and invasion | Q37333610 | ||
| Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells | Q37351516 | ||
| PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system | Q37382529 | ||
| Differentiation and cancer in the mammary gland: shedding light on an old dichotomy. | Q37401876 | ||
| NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction | Q37615954 | ||
| Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? | Q37638254 | ||
| Epithelial organization, cell polarity and tumorigenesis | Q37904131 | ||
| Loss of PTEN expression as a prognostic marker for tongue cancer | Q38458513 | ||
| PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients | Q38738670 | ||
| Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling | Q39046697 | ||
| MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. | Q39077654 | ||
| MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells | Q39160607 | ||
| MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer | Q39183436 | ||
| MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. | Q39356550 | ||
| A novel model of human implantation: 3D endometrium-like culture system to study attachment of human trophoblast (Jar) cell spheroids | Q39459919 | ||
| MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway | Q39560767 | ||
| Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes | Q39608598 | ||
| A robust immunohistochemical assay for detecting PTEN expression in human tumors | Q39646962 | ||
| PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. | Q40178894 | ||
| Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. | Q40464853 | ||
| Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities | Q40485163 | ||
| Ultrastructure of endometrial epithelial cells in a three-dimensional cell culture system for human implantation studies | Q40970211 | ||
| Ultrastructural characterization of two new human endometrial carcinoma cell lines and normal human endometrial epithelial cells cultured on extracellular matrix | Q41137235 | ||
| MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN. | Q41412784 | ||
| Culture of human endometrial cells under polarizing conditions | Q42484600 | ||
| Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase | Q43038834 | ||
| Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma | Q43049041 | ||
| Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China | Q43456119 | ||
| Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer | Q43675669 | ||
| Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase | Q44298545 | ||
| Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues | Q44529091 | ||
| Scaffold-mediated symmetry breaking by Cdc42p | Q44661094 | ||
| Growth of mouse endometrial luminal epithelial cells in vitro: functional integrity of the oestrogen receptor system and failure of oestrogen to induce proliferation | Q44973323 | ||
| Best practice for PTEN gene and protein assessment in anatomic pathology | Q46825031 | ||
| Cell polarity and cancer--cell and tissue polarity as a non-canonical tumor suppressor. | Q52586148 | ||
| The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. | Q53956406 | ||
| P921 | main subject | endometrial cancer | Q944777 |
| P304 | page(s) | 31-40 | |
| P577 | publication date | 2014-11-18 | |
| P1433 | published in | Methods | Q6823859 |
| P1476 | title | Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model | |
| P478 | volume | 77-78 |
| Q87056285 | A rapid guide to PTEN function |
| Q39026766 | Endometrial Carcinoma: Specific Targeted Pathways. |
| Q57170070 | Modeling Endometrial Cancer: Past, Present, and Future |
| Q64114534 | Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology |
| Q35967172 | Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer |
Search more.